Emergent Biosolutions reported $-34700000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -15.3M 28.41M
Akebia Therapeutics AKBA:US $ -54.89M 24.46M
ALKERMES ALKS:US -19659000 24.08M
Alnylam Pharmaceuticals ALNY:US $ -181.68M 35.52M
Amarin AMRN:US $ -13.07M 21.85M
Ani Pharmaceuticals ANIP:US $ -3562000 11.99M
Biomarin Pharmaceutical BMRN:US $ -53.22M 64.89M
Chimerix CMRX:US -18600000 785K
Coherus Biosciences CHRS:US $ -32.79M 8.62M
Emergent Biosolutions EBS:US $ -34.7M 49.2M
Exact Sciences EXAS:US $ -162.02M 9.64M
Exelixis EXEL:US $ 51.62M 71.39M
Flexion Therapeutics FLXN:US $ -23658000 6.78M
Glaxosmithkline GSK:US $ 1938M 263M
Heron Therapeutics HRTX:US $ -51.71M 8.76M
Immunogen IMGN:US $ -34.23M 6.86M
Intercept Pharmaceuticals ICPT:US $ 10.29M 9.53M
Ironwood Pharmaceuticals IRWD:US $ 65.17M 0.07M
JAZZ PHA JAZZ:US $ 28.37M 97.96M
Lexicon Pharmaceuticals LXRX:US -22962000 5M
Lonza Group LONN:SW 317M 34M
Merk MRK:US $ 4826M 3212M
Moderna Inc MRNA:US 3.56B 496M
Myriad Genetics MYGN:US $ -79.9M 59.1M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Opko Health OPK:US $ 37.83M 32.26M
Pacira Pharmaceuticals PCRX:US $ 31.43M 3.41M
Pfizer PFE:US $ 7647M 1733M
Ptc Therapeutics PTCT:US $ -93.08M 5.42M
Sarepta Therapeutics SRPT:US $ -38.95M 128.63M
Seattle Genetics SGEN:US $ -297.96M 208.36M
Teva Pharmaceutical Industries TEVA:US $ 623M 41M
United Therapeutics UTHR:US $ 228.7M 8.8M
Vanda Pharmaceuticals VNDA:US $ 10.82M 1.55M
Xoma XOMA:US $ -3345000 19K